Dr. Robert G. Silverman is a chiropractic doctor, clinical nutritionist and author of, “Inside-Out Health: A Revolutionary Approach to Your Body,” an Amazon No. 1 bestseller in 2016. The ACA Sports Council named Dr. Silverman “Sports Chiropractor of the Year” in 2015. He also maintains a busy private practice as founder of Westchester Integrative Health Center, which specializes in the treatment of joint pain using functional nutrition along with cutting-edge, science-based, nonsurgical approaches.

Dr. Silverman is also on the advisory board for the Functional Medicine University and is a seasoned health and wellness expert on both the speaking circuits and within the media. He has appeared on FOX News Channel, FOX, NBC, CBS, CW affiliates as well as The Wall Street Journal and NewsMax, to name a few. He was invited as a guest speaker on “Talks at Google” to discuss his current book. As a frequent published author in peer-reviewed journals and other mainstream publications, including Integrative Practitioner, MindBodyGreen, Muscle and Fitness, The Original Internist and Holistic Primary Care journals, Dr. Silverman is a thought leader in his field and practice.

Tags: low back pain | hyperalgesia | laser

Breakthrough Solution for Back Pain

Wednesday, 29 August 2018 04:29 PM Current | Bio | Archive

Low back pain will affect some 80 percent of all adult Americans at some point. But it’s not just an American problem. Low back pain is becoming more prevalent around the world, having risen by more than 50 percent since 1990.

As low back pain becomes a more international problem, the costs to patients, healthcare systems, and society escalates. In the U.S. alone, total costs exceed $100 billion per year, two-thirds of which are a result of lost wages and reduced productivity.

Traditional medical treatment of low back pain often involves prescription painkillers, particularly opioids. The risk of abuse and addiction with these drugs is well known. In 2016, the CDC issued revised prescribing guidelines that recommend sharply cutting the duration of any pain-killer prescription.

Most importantly, these drugs fail to be effective in the long term.

A 2016 meta-analysis of 20 studies of opioids for low back pain published in JAMA Internal Medicine found that opioid analgesics for chronic low back pain provided only modest short-term pain relief, and only for some patients.

In many of the studies analyzed, more than half of the participants in the trial dropped out due to adverse side effects of these dangerous drugs. None of the studies showed clinically important pain relief (defined as more than 20 points improvement on a 100-point scale).

And those who did get some relief from pain took doses that were much higher than recommended.

The meta-analysis brought out an important point about opioid studies: Almost all are short term. Very few high-quality studies have looked at the long-term effects of opioid use for patients with chronic low back pain.

A recent study over a 12-month period found that treatment with opioids was no better than treatment with nonopioid medications such as ibuprofen for improving pain-related function.

In addition to offering little help to patients, opioid drugs can make chronic pain worse. For some patients, using opioids can induce hyperalgesia, a paradoxical response whereby patients who take these drugs become more sensitive to painful stimuli.

The mechanisms behind hyperalgesia are still unclear, but the risk that painkilling drugs could make a patient more sensitive to pain is clear. Hyperalgesia is another potential harm to add to the long list of bad side effects of opioid use.

The evidence is very clear: Opioids not only aren’t a solution to low back pain. Nondrug treatments such as nonthermal low-level laser therapy led by chiropractors are far preferable. They’re safe, they’re supported by research, they work, and they’re cost effective.

In July 2018, the Erchonia FX 635 low-level laser received official FDA clearance for relief of chronic low back pain. Chiropractors now have a powerful new tool to help their patients relieve chronic low back pain and get back to work and normal activity.

The clinical trial conducted to obtain FDA clearance was designed to test the effectiveness of the laser in providing relief of chronic low back pain of musculoskeletal origin.

Fifty-eight people completed the study; half were treated with the laser and half were treated with a placebo (sham laser 635nm LED). All the participants rated their pain as 40 or greater on the 0 to 100 pain scale. The average duration of low back pain for the participants was 97.8 months (approximately eight years). The majority of the participants had had bilateral low back pain with an average pain rating of 59.10 on the scale.

All the participants received eight 20-minute procedure administrations across the lower back region with the Erchonia FX-635 laser (active or sham) across a four-week period: two procedures per week, each procedure three to four days apart.

Of those who received the active laser treatment, 72.4 percent attained a 30 percent or greater decrease in chronic low back pain.

No adverse events were reported during the study duration. At the end of three months, the reduction in pain was sustained, even though no additional treatment was administered after the first month.

Low level laser treatment (LLLT) works by stimulating cell activation processes which, in turn, intensify physiologic activity. The light energy from the laser initiates a cascade of reactions that stimulate the mitochondria to increase the production of ATP.

The laser light stimulates the release of natural healing chemicals that lead to rapid cell growth, increased metabolic activity, increased angiogenesis, improved vascular activity, suppression of the COX-2 inflammatory pathway, and decreased inflammation.

The specific wavelength (color) of the laser light is responsible for influencing the biochemical cascades. Research has shown that a wavelength of 635 nm is ideal for accelerating healing and reducing post-injury inflammation. The coherent, pulsed light delivered by the Erchonia laser insures deep tissue stimulation and absorption.

Laser treatment is painless. There’s no sensation of heat and the skin and tissue aren’t damaged in any way. The laser light is delivered to the lower back area in a moving circular pattern for 20 minutes. The patient does not need to be attended during this time.

For more information about Dr. Silverman, please visit


© 2019 NewsmaxHealth. All rights reserved.

1Like our page
Low back pain will affect some 80 percent of all adult Americans at some point. But it’s not just an American problem. Low back pain is becoming more prevalent around the world, having risen by more than 50 percent since 1990.
low back pain, hyperalgesia, laser
Wednesday, 29 August 2018 04:29 PM
Newsmax Media, Inc.

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

© Newsmax Media, Inc.
All Rights Reserved